Chimeric Therapeutics is the ASX leader in cell therapy.
As the only clinical stage, cell therapy biotechnology company in Australia, our focus is on discovering, developing and commercialising novel cell therapies with the most potential for patients.
ASX: CHM
This company has no teams yet
This company has no offices yet